Last reviewed · How we verify

NCT04354506

Smart Phone Atrial Fibrillation Application

Status unknown Last updated 21 April 2020
What this trial tests

trial in Atrial Fibrillation in 5,000 participants. Status unknown.

Timeline
1 May 2020
Primary endpoint
1 June 2021
1 June 2022

Quick facts

Lead sponsorInstitute of Longevity
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment5,000
Start date1 May 2020
Primary completion1 June 2021
Estimated completion1 June 2022

Conditions studied

Sponsor

Institute of Longevity

Who can join

Adults 18 to 85, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with atrial fibrillation will have the chance to assess their disease management through an application available for free in Android and IOS smart devices

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04354506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing